August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Minhua Chu: Shenzhen Pregene Biopharma Received FDA Orphan Drug Designation
Aug 28, 2025, 14:03

Minhua Chu: Shenzhen Pregene Biopharma Received FDA Orphan Drug Designation

Minhua Chu, Managing Partner at TransitionValue Partner, shared a post on X:

Shenzhen Pregene Biopharma has received Orphan Drug Designation (ODD) from the FDA for its CD19/CD22-targeted CAR-T therapy for the treatment of acute lymphoblastic leukemia (ALL).

Pregene’s CD19/CD22-targeted CAR-T therapy is in preclinical stage. It is currently undergoing an Investigator-Initiated Trial (IIT) in collaboration with a Chinese hospital.

Results show that all six patients receiving the CAR-T therapy for the first time achieved complete remission (CR), with an objective response rate (ORR) of 100% and a minimal residual disease (MRD) negativity rate of 100%.”

More posts featuring Minhua Chu on OncoDaily.